Literature DB >> 3759580

Dose response to preoperative irradiation in rectal cancer: implications for local control and complications associated with sphincter sparing surgery and abdominoperineal resection.

G A Fortier, R J Krochak, J A Kim, W C Constable.   

Abstract

Sixty patients with locally advanced adenocarcinoma of the rectum have been treated with preoperative high dose pelvic irradiation at the University of Virginia and Rockingham Memorial Hospital. Fifty-six patients showed no evidence of distant metastases at surgery. A dose response was observed with a 67% incidence of local control with 4000 cGy vs. 91% incidence with 5000 cGy. For the 52 patients who received curative surgery, there has been no local failure alone; 6 of these patients have had local plus distant failure and 16 have had distant failure only. Forty-three percent had anterior resection (AR) and 57% had abdominoperineal resections (APR). The major complication rate was 5% and the minor 14%. No increase in complications or decrease in local control was found between APR and AR. Five-year actuarial survival was 64% for lesions limited to the bowel wall, 59% for node negative lesions with disease extending through the wall, and 23% for node positive patients.

Entities:  

Mesh:

Year:  1986        PMID: 3759580     DOI: 10.1016/0360-3016(86)90278-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Evaluation of preoperative radiation therapy in operable colorectal cancer.

Authors:  W T Sause; T F Pajak; R D Noyes; R Dobelbower; J Fischbach; S Doggett; M Mohiuddin
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

Review 2.  Pre-operative and post-operative radiotherapy and rectal cancer.

Authors:  L Påhlman; B Glimelius
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

3.  Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma.

Authors:  A M Lowy; T A Rich; J M Skibber; R A Dubrow; S A Curley
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

Review 4.  Current options for the management of rectal cancer.

Authors:  Bert H O'Neil; Joel E Tepper
Journal:  Curr Treat Options Oncol       Date:  2007-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.